Cargando…

Renoprotective Potency of Sitagliptin versus Pioglitazone in Type 2 Diabetic Patients: Impact on LncMIAT

[Image: see text] Background: Diabetes mellitus (DM) represents one of the most important reasons for chronic kidney diseases due to the high level of blood glucose that destructs blood vessels. Objective: The present study focused on investigating the protective impact of sitagliptin on kidney comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandeil, Mohamed A., Shaarawy, Mohamed A., Mourad, Hamdy A., Mahmoud, Mohamed O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652733/ https://www.ncbi.nlm.nih.gov/pubmed/38024775 http://dx.doi.org/10.1021/acsomega.3c07008

Ejemplares similares

NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-β2
por: Ding, Xue, et al.
Publicado: (2023)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
por: Mega, Cristina, et al.
Publicado: (2017)

Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs
por: Helmy, Mai M., et al.
Publicado: (2015)

Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
por: Wang, Ziyang, et al.
Publicado: (2022)

Renoprotective effect of curcumin against the combined oxidative stress of diabetes and nicotine in rats
por: IBRAHIM, ZEIN SHABAN, et al.
Publicado: (2016)

LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
por: Tan, Jin, et al.
Publicado: (2019)

lncRNA MIAT promotes cell invasion and migration in esophageal cancer
por: Zhang, Weiguo, et al.
Publicado: (2020)

Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure
por: Yang, Liu, et al.
Publicado: (2021)

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin
por: Jameshorani, Maryam, et al.
Publicado: (2017)

Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats
por: Afzal, Sheryar, et al.
Publicado: (2020)

Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
por: Todoerti, Katia, et al.
Publicado: (2021)

The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
por: Ohki, Takamasa, et al.
Publicado: (2012)

Downregulation of lncRNA Miat contributes to the protective effect of electroacupuncture against myocardial fibrosis
por: Qi, Wenchuan, et al.
Publicado: (2022)

Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy
por: El-Kady, Mohamed M., et al.
Publicado: (2021)

Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial
por: Chawla, Shalini, et al.
Publicado: (2013)

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
por: Kashiwagi, Atsunori, et al.
Publicado: (2011)

Elevated lncRNA MIAT in peripheral blood mononuclear cells contributes to post-menopausal osteoporosis
por: Li, Rui, et al.
Publicado: (2022)

Association of Angio-LncRNAs MIAT rs1061540/MALAT1 rs3200401 Molecular Variants with Gensini Score in Coronary Artery Disease Patients Undergoing Angiography
por: Elwazir, Mohamed Y., et al.
Publicado: (2022)

DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide
por: Wysham, C, et al.
Publicado: (2011)

Pioglitazone abrogates testicular damage induced by testicular torsion/detorsion in rats
por: Mahmoud, Nevertyty Mohamed, et al.
Publicado: (2019)

Loss of lncRNA MIAT ameliorates proliferation and fibrosis of diabetic nephropathy through reducing E2F3 expression
por: Ji, Ting‐Ting, et al.
Publicado: (2020)

Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer
por: Xu, Hao, et al.
Publicado: (2020)

LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer
por: Ye, Ting, et al.
Publicado: (2021)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Catechin relieves hypoxia/reoxygenation‐induced myocardial cell apoptosis via down‐regulating lncRNA MIAT
por: Cong, Lin, et al.
Publicado: (2020)

Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells
por: Feng, Tao, et al.
Publicado: (2022)

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
por: Zhan, Yating, et al.
Publicado: (2023)

MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell Lines
por: Feriancikova, Barbara, et al.
Publicado: (2021)

Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats
por: Saad, Mohamed I., et al.
Publicado: (2015)

LncRNA-MIAT-Mediated miR-214-3p Silencing Is Responsible for IL-17 Production and Cardiac Fibrosis in Diabetic Cardiomyopathy
por: Qi, Yanqing, et al.
Publicado: (2020)

Renoprotection against complete unilateral ureteric obstruction: Is there an ultimate choice?
por: Khalil, Khaled I., et al.
Publicado: (2012)

The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis
por: Al-Aloul, Mohamed, et al.
Publicado: (2019)

Chlamydia trachomatis induces lncRNA MIAT upregulation to regulate mitochondria‐mediated host cell apoptosis and chlamydial development
por: Luo, Fangzhen, et al.
Publicado: (2021)

ADSC Exosomes Mediate lncRNA-MIAT Alleviation of Endometrial Fibrosis by Regulating miR-150-5p
por: Shao, Xiaowen, et al.
Publicado: (2021)

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week double-blind study
por: Russell-Jones, David, et al.
Publicado: (2012)

lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy
por: Zhou, Xiang, et al.
Publicado: (2017)

The effect of some natural antioxidants against cisplatin-induced neurotoxicity in rats: behavioral testing
por: Kandeil, Mohamed A., et al.
Publicado: (2020)

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
por: Sayari, Saba, et al.
Publicado: (2018)

LncRNA MIAT enhances systemic lupus erythematosus by upregulating CFHR5 expression via miR-222 degradation
por: Zhang, Yali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ikq7in2gaetd4pa55q8bqej8ai